Compare · TMO vs VICR
TMO vs VICR
Side-by-side comparison of Thermo Fisher Scientific Inc (TMO) and Vicor Corporation (VICR): market cap, price performance, sector, and recent activity on the wire.
Summary
- TMO operates in Industrials, while VICR operates in Technology - the two are in different parts of the market.
- TMO is the larger of the two at $232.26B, about 25.9x VICR ($8.97B).
- TMO has been more active in the news (10 items in the past 4 weeks vs 5 for VICR).
- TMO has more recent analyst coverage (25 ratings vs 13 for VICR).
- Company
- Thermo Fisher Scientific Inc
- Vicor Corporation
- Price
- $628.06-0.13%
- $194.73+2.55%
- Market cap
- $232.26B
- $8.97B
- 1M return
- -
- -5.47%
- 1Y return
- -
- +277.20%
- Industry
- Industrial Machinery/Components
- Industrial Machinery/Components
- Exchange
- NYSE
- NASDAQ
- IPO
- News (4w)
- 10
- 5
- Recent ratings
- 25
- 13
Thermo Fisher Scientific Inc
Thermo Fisher Scientific Inc. offers life sciences solutions, analytical instruments, specialty diagnostics, and laboratory products and service worldwide. The company's Life Sciences Solutions segment offers reagents, instruments, and consumables for biological and medical research, discovery, and production of drugs and vaccines, as well as diagnosis of infections and diseases to pharmaceutical, biotechnology, agricultural, clinical, healthcare, academic, and government markets. Its Analytical Instruments segment provides instruments, consumables, software, and services for use in laboratory, on production line, and in field for pharmaceutical, biotechnology, academic, government, environmental, and other research and industrial markets, as well as clinical laboratories. The company's Specialty Diagnostics segment offers liquid, ready-to-use, and lyophilized immunodiagnostic reagent kits, as well as calibrators, controls, and calibration verification fluids; ImmunoCAP for allergy and asthma tests, and EliA for autoimmunity tests; dehydrated and prepared culture media, collection and transport systems, instrumentation, and consumables; human leukocyte antigen typing and testing for organ transplant market; and healthcare products. Its Laboratory Products and Services segment provides laboratory refrigerators and freezers, ultralow-temperature freezers, and cryopreservation storage tanks; temperature control, sample preparation and preservation, centrifugation, and biological safety cabinet products; water analysis instruments; laboratory plastics products; laboratory chemicals; and pharma services. The company offers products and services through a direct sales force, customer-service professionals, electronic commerce, third-party distributors, and catalogs. It has a strategic alliance with the University of California, San Francisco. The company was incorporated in 1956 and is based in Waltham, Massachusetts.
Vicor Corporation
Vicor Corporation, together with its subsidiaries, designs, develops, manufactures, and markets modular power components and power systems for converting electrical power in the United States, Europe, the Asia Pacific, and internationally. The company offers a range of brick-format DC-DC converters; complementary components; and input and output voltage, and output power products, as well as electrical and mechanical accessories. It also provides custom power systems solutions. The company serves independent manufacturers of electronic devices, original equipment manufacturers, and their contract manufacturers in the aerospace and aviation, defense electronics, industrial automation and equipment, instrumentation, test equipment, solid state lighting, telecommunications and networking infrastructure, and vehicles and transportation markets. Vicor Corporation was founded in 1981 and is headquartered in Andover, Massachusetts.
Latest TMO
- Sr. Vice President & CFO Meyer James covered exercise/tax liability with 31 shares, decreasing direct ownership by 0.53% to 5,830 units (SEC Form 4)
- Chairman & CEO Casper Marc N exercised 20,000 shares at a strike of $309.63 and sold $12,561,823 worth of shares (20,000 units at $628.09) as part of a pre-agreed trading plan, decreasing direct ownership by 0.00% to 123,925 units (SEC Form 4)
- Sr. VP and Chief HR Officer Britt Lisa P. sold $7,014,093 worth of shares (11,440 units at $613.12) and exercised 11,440 shares at a strike of $418.32, decreasing direct ownership by 0.00% to 14,784 units (SEC Form 4)
- Executive Vice President Shafer Michael D exercised 25,500 shares at a strike of $370.58 and sold $15,300,000 worth of shares (25,500 units at $600.00) as part of a pre-agreed trading plan (SEC Form 4)
- Thermo Fisher Scientific Completes Sale of its Microbiology Business to Astorg
- VP & Chief Accounting Officer Holmes Joseph R. exercised 420 shares at a strike of $309.63 and sold $245,620 worth of shares (420 units at $584.81) (SEC Form 4)
- Chairman & CEO Casper Marc N exercised 275 shares at a strike of $309.63 and sold $2,862,002 worth of shares (4,883 units at $586.12) as part of a pre-agreed trading plan (SEC Form 4)
- Sr. VP and Chief HR Officer Britt Lisa P. exercised 5,850 shares at a strike of $309.63 and sold $3,393,000 worth of shares (5,850 units at $580.00), decreasing direct ownership by 0.00% to 14,784 units (SEC Form 4)
- Chairman & CEO Casper Marc N exercised 10,000 shares at a strike of $309.63 and sold $8,616,967 worth of shares (15,000 units at $574.46) as part of a pre-agreed trading plan, decreasing direct ownership by 0.00% to 123,925 units (SEC Form 4)
- Chairman & CEO Casper Marc N exercised 10,000 shares at a strike of $309.63 and sold $8,628,434 worth of shares (15,000 units at $575.23) as part of a pre-agreed trading plan, decreasing direct ownership by 0.00% to 123,925 units (SEC Form 4)
Latest VICR
- Director Anderson Samuel J exercised 3,409 shares at a strike of $46.94, increasing direct ownership by 85% to 7,443 units (SEC Form 4)
- Director Lavie Zmira exercised 908 shares at a strike of $44.07 and sold $227,000 worth of shares (908 units at $250.00) (SEC Form 4)
- Director Anderson Samuel J sold $523,640 worth of shares (2,073 units at $252.60), decreasing direct ownership by 34% to 4,034 units (SEC Form 4)
- Amendment: SEC Form SCHEDULE 13G/A filed by Vicor Corporation
- Corp. VP-Global Sales & Mktg. Davies Philip D exercised 3,072 shares at a strike of $41.61 and sold $650,308 worth of shares (3,072 units at $211.69) as part of a pre-agreed trading plan (SEC Form 4)
- SEC Form 10-Q filed by Vicor Corporation
- Director Eichten Estia J exercised 5,987 shares at a strike of $33.42, increasing direct ownership by 6% to 104,825 units (SEC Form 4)
- Director Lavie Zmira exercised 1,216 shares at a strike of $32.89 and sold $273,260 worth of shares (1,216 units at $224.72) (SEC Form 4)
- Vicor Corporation filed SEC Form 8-K: Results of Operations and Financial Condition
- Vicor Corporation Reports Results for the Second Quarter Ended June 30, 2026